#ACR21 #SLE SLE – Treatment: New Agents, Old Agents Pooled data from 2 phase 3 trials (TULIP 1 and 2) ⏬LLDAS is an attainable T2T endpoint in adult SLE trials ⏬Anifrolumab treatment associated with earlier and more sustained LLDAS in adult SLE https://t.co/bxGlVsJOZC